This study evaluates differences in meningioma frequency and severity between different groups. Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07418775.
Locations matching your search criteria
United States
California
San Francisco
University of California San FranciscoStatus: Approved
Contact: David Ronan Raleigh
Phone: 312-480-1671
PRIMARY OBJECTIVES:
I. To assess prevalence and distribution of social and structural determinants of health (SSDH) among meningioma patients.
II. To assess disparities in SSDH among meningioma patients of different races.
OUTLINE: This is an observational study.
Patients complete a survey and have their medical records reviewed on study.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationUniversity of California San Francisco
Principal InvestigatorDavid Ronan Raleigh
